RSS feed

Publications by Ranveig Røtterud

12 publications found

Original articles

Mauri D, Kamposioras K, Tsali L, Dambrosio M, De Bari B, Hindi N, Salembier C, Nixon J, Dimitrios T, Alongi F, Hameed H, Valachis A, Papadimitriou K, Corradini S, Popovic L, Kopecky J, Rodriguez A, Antunac K, Yi J, Lovey J, Strojan P, Saraireh H, Røtterud R, Chojnacka M, Olalla SC et al. (2022)
COVID-19 Vaccinations: Summary Guidance for Cancer Patients in 28 Languages: Breaking Barriers to Cancer Patient Information
Rev Recent Clin Trials, 17 (1), 11-14
DOI 10.2174/1574887116666211028145848, PubMed 34967300

Elliott J, Rotterud R, Maddox-Smith A, Bagshaw K, Cirefice LBF, Knight A, Necchi A, Rek A, Winterbottom A, Makaroff LE (2019)
The bladder cancer patient survey: Global perspectives on awareness and treatment of bladder cancer
J. CANCER POLICY, 22, 100207
DOI 10.1016/j.jcpo.2019.100207

Røtterud R, Malmström PU, Wahlqvist R, Taskén KA (2010)
The star chart to Ta bladder cancer: an unsophisticated analysis of two-dimensional gel electrophoresis proteome maps
Scand J Urol Nephrol, 44 (2), 76-83
DOI 10.3109/00365590903510729, PubMed 20059407

Røtterud R, Fosså SD, Nesland JM (2007)
Protein networking in bladder cancer: immunoreactivity for FGFR3, EGFR, ERBB2, KAI1, PTEN, and RAS in normal and malignant urothelium
Histol Histopathol, 22 (4), 349-63
DOI 10.14670/HH-22.349, PubMed 17290345

Røtterud R, Nesland JM, Berner A, Fosså SD (2005)
Expression of the epidermal growth factor receptor family in normal and malignant urothelium
BJU Int, 95 (9), 1344-50
DOI 10.1111/j.1464-410X.2005.05497.x, PubMed 15892828

Røtterud R, Pettersen EO, Berner A, Holm R, Olsen DR, Fosså SD (2002)
Cell cycle inhibitors and outcome after radiotherapy in bladder cancer patients
Acta Oncol, 41 (5), 463-70
DOI 10.1080/028418602320405069, PubMed 12442923

Røtterud R, Berner A, Holm R, Skovlund E, Fosså SD (2001)
p53, p21 and mdm2 expression vs the response to radiotherapy in transitional cell carcinoma of the bladder
BJU Int, 88 (3), 202-8
DOI 10.1046/j.1464-410x.2001.02268.x, PubMed 11488730

Røtterud R, Skomedal H, Berner A, Danielsen HE, Skovlund E, Fosså SD (2001)
TP53 and p21WAF1/CIP1 behave differently in euploid versus aneuploid bladder tumours treated with radiotherapy
Acta Oncol, 40 (5), 644-52
DOI 10.1080/028418601750444213, PubMed 11669339

Osen I, Fosså SD, Majak B, Røtterud R, Berner A (1998)
Prognostic factors in muscle-invasive bladder cancer treated with radiotherapy: an immunohistochemical study
Br J Urol, 81 (6), 862-9
DOI 10.1046/j.1464-410x.1998.00657.x, PubMed 9666772

Other articles

Røtterud R (2016)
[Not Available]
Tidsskr Nor Laegeforen, 136 (7), 591
DOI 10.4045/tidsskr.16.0302, PubMed 27094654

Theses

Røtterud R (2005)
Invasive bladder cancer: factors involved in development, progression, and radiation response
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 240, 1 b. (flere pag.)
BIBSYS 05002969x, ISBN 82-8072-179-7

Røtterud R (1996)
Organdistribusjonsstudie av dimetakrylaten UEDMA: utvikling av metod
R. Røtterud, [Trondheim], 100 bl.
BIBSYS 961665785